Hypothyroidism and Menopause: Root Causes and Relief

By Dr. Matt Gianforte, D.C. | Functional Medicine Clinician

Yes, hypothyroidism and menopause can happen at the same time, and because both can cause fatigue, weight gain, brain fog, low mood and poor sleep, one is easily mistaken for the other. In a study of more than 53,000 women, overt hypothyroidism was more common in the late menopausal transition and after menopause than before it (Kim et al., Thyroid, 2022), so thyroid testing belongs in a midlife symptom workup.

A woman in her early 50s may arrive at an appointment with persistent fatigue, weight gain, brain fog, low mood, disrupted sleep, and a changing menstrual pattern. She may hear that her thyroid test is “normal” and that the symptoms are menopause. Sometimes that explanation is correct. Sometimes hypothyroidism is present too, and the overlap allows a treatable thyroid problem to remain unnoticed.

• Hypothyroidism and menopause can occur together, and their symptoms often overlap.
• Hypothyroidism becomes more common in women with age (Gietka-Czernel, 2017), and overt hypothyroidism appears more often during the late menopausal transition and postmenopause.
• Fatigue, weight change, hair thinning, mood changes, sleep problems, and cognitive symptoms need context rather than a single-label explanation.
• A TSH result is important, but clinicians may need a broader evaluation when symptoms persist or treatment changes.
• Thyroid replacement and menopausal hormone therapy require thoughtful follow-up because undertreatment and overtreatment carry different risks.
• Nutrition, sleep, stress regulation, movement, medication review, and targeted testing can help clarify which systems need support.

Why Hypothyroidism and Menopause Are So Often Confused

Consider a 52-year-old woman who has gradually gained weight, feels exhausted after ordinary tasks, struggles to concentrate, and wakes during the night. Her periods have become irregular, and she has occasional hot flashes. A basic TSH test falls within the laboratory's reference interval, so the symptoms are attributed to menopause.

That conclusion may miss the central issue. Menopause and hypothyroidism can coexist, and the presence of one doesn't rule out the other. Fatigue, weight change, depression, hair loss, cognitive slowing, sleep disturbance, and menstrual changes can arise from either condition, while hot flashes and night sweats can make the entire picture feel unmistakably menopausal.

Why age and timing matter

Hypothyroidism is consistently more common in women than men and increases with age. One review reported that women were affected 7 to 10 times more often than men. The same review found the annual risk rose from 1.4 per 1,000 women at ages 18–24 to 6.7 per 1,000 at ages 65–74 and 14 per 1,000 at ages 75–80 (Gietka-Czernel, Menopause Review, 2017).

The review also reported elevated TSH in about 7.6% of women overall, rising to 17% in women over 70. Menopause-focused research found overt hypothyroidism was more prevalent in late perimenopause and postmenopause than before menopause, with adjusted prevalence ratios of 1.61 and 1.66, respectively (Kim et al., Thyroid, 2022).

The diagnostic blind spot

The phrase “normal labs” can sound definitive, but it only describes the tests that were ordered and how the result compares with a population reference interval. It doesn't explain every symptom, assess every thyroid marker, or determine whether menopause, autoimmune thyroid disease, medication effects, nutrient insufficiency, sleep disruption, and stress physiology are acting together.

Practical rule: A persistent symptom deserves a clinical explanation, even when one laboratory value falls inside a broad reference range.

A practical first step is laying a symptom timeline next to TSH, free T4 and thyroid antibodies, along with the menstrual history and any hormone or thyroid medication, before deciding what else to test. Functional medicine practitioners typically assess both systems simultaneously. The question isn't whether symptoms are caused by menopause or hypothyroidism. The more useful question is whether thyroid function, ovarian hormone changes, metabolic health, and recovery systems are each contributing.

The Hormonal Physiology Behind the Overlap

The thyroid and ovarian systems communicate through the broader endocrine network. TSH acts as a signal from the pituitary gland to the thyroid, while T4 and T3 influence energy production, temperature regulation, bowel function, heart rate, and brain activity. Estrogen and progesterone affect tissues that respond to thyroid hormones, and the stress response can alter how the body prioritizes energy.

A helpful analogy is a house thermostat. TSH is part of the thermostat system, while thyroid hormone production, T4-to-T3 conversion, transport, and cellular response determine how much heat reaches the rooms. A thermostat reading alone can't tell whether the furnace is working efficiently or whether the rooms are warm.

Estrogen, binding proteins, and available hormone

Estrogen influences thyroid-binding globulin, or TBG, a transport protein that binds thyroid hormones in the bloodstream. Changes in estrogen exposure can alter the relationship between total thyroid hormone and the free fraction available to tissues. This becomes clinically relevant when a person starts or changes oral menopausal hormone therapy, because total hormone values may not reflect the same free-hormone status.

Menopause itself involves a shifting reproductive environment rather than one uniform hormonal state. Perimenopause can include fluctuating estrogen and progesterone, while postmenopause brings a different baseline. These changes may reveal symptoms that had previously remained below the threshold of notice.

Women seeking a broader explanation of reproductive hormone changes may also review the guide to natural hormone balance for women and the menopause support guide, while keeping thyroid monitoring as a separate clinical responsibility.

Stress, sleep, and conversion

Chronic psychological stress, inadequate sleep, under-fueling, illness, and excessive training can influence the hypothalamic-pituitary-adrenal axis. Cortisol and other stress signals may affect thyroid signaling and peripheral conversion, although a “functional hypothyroid state” shouldn't be diagnosed from symptoms alone. Proper assessment requires history, examination, medication review, and appropriate laboratory testing.

The endocrine systems also change with age. A review of thyroid function after menopause found a substantial burden of clinical and subclinical thyroid disease in postmenopausal women and noted that thyroid symptoms can be hard to tell apart from postmenopausal complaints (Schindler, Gynecological Endocrinology, 2003). That finding supports vigilance, not automatic treatment.

For a deeper review of how clinicians organize reproductive and thyroid evaluation, see hormone testing for women.

Symptom Decoder for Thyroid and Menopausal Changes

Symptoms provide clues, but they don't establish a diagnosis. The strongest interpretation comes from combining symptom quality, timing, physical findings, personal history, medication exposure, and laboratory results.

Hypothyroidism-Predominant	Overlapping Symptoms	Menopause-Predominant
Cold intolerance	Fatigue	Hot flashes
Constipation	Weight change	Vaginal dryness
Dry skin	Depression or low mood	Irregular periods during the transition
Slower heart rate	Hair thinning	Night sweats and related sleep disruption
Elevated cholesterol	Brain fog	Genitourinary discomfort

Clues that increase suspicion of thyroid dysfunction

A gradual metabolic slowdown over months, persistent cold intolerance, constipation, dry skin, a slower heart rate, or a family history of autoimmune thyroid disease may point toward thyroid evaluation. Delayed deep tendon reflexes and symptoms that continue despite appropriate menopause treatment also deserve attention.

By contrast, sudden hot flashes, night sweats, vaginal dryness, and cycle changes fit more closely with menopausal transition. These distinctions aren't absolute. A woman can experience both a thyroid disorder and menopause, which means a symptom may have more than one contributor.

A symptom journal can make the pattern easier to interpret. Record sleep, temperature sensitivity, bowel frequency, hot flashes, palpitations, menstrual changes, medication timing, and major stressors. A simple one-page checklist of these items can help organize symptom history before an appointment.

When symptoms need a wider lens

The same 2003 review reported clinical thyroid disease in about 2.4% of postmenopausal women and subclinical thyroid disease in about 23.2%. Among those with subclinical disease, 73.8% were hypothyroid (Schindler, 2003). These figures don't mean every symptom requires thyroid medication. They do show why clinicians shouldn't dismiss thyroid function during menopause.

Persistent fatigue can also reflect anemia, sleep apnea, medication effects, depression, nutritional insufficiency, or metabolic disease. Readers seeking a broader fatigue framework can review why fatigue can persist.

Functional Medicine Lab Testing Beyond Basic TSH

TSH remains central to thyroid assessment, but TSH alone may not answer every clinical question. The appropriate panel depends on symptoms, medical history, examination findings, pregnancy potential, medications, thyroid treatment, and whether autoimmune disease is suspected.

An evaluation may include TSH, free T4, free T3, thyroid peroxidase antibodies, and thyroglobulin antibodies. Reverse T3, SHBG, cortisol, DHEA-S, ferritin, vitamin D, blood count, metabolic markers, and lipid testing may be considered when the clinical picture supports them.

What each marker can contribute

• TSH: A pituitary signal that helps guide thyroid replacement. The American Thyroid Association guideline identifies TSH as the most reliable marker of replacement adequacy and recommends a therapeutic target within 0.4–4.0 mIU/L (Jonklaas et al., Thyroid, 2014).
• Free T4: The circulating unbound form of thyroxine, useful for assessing available T4.
• Free T3: The unbound active thyroid hormone. Interpretation must account for assay limitations and the wider clinical picture.
• TPO and Tg antibodies: Markers that can support evaluation for autoimmune thyroid disease.
• Reverse T3: A metabolite that some clinicians assess in selected cases, although it shouldn't replace established testing or clinical judgment.
• SHBG: A protein affected by thyroid and sex-hormone physiology. It can add context but isn't a stand-alone measure of tissue thyroid activity.
• Ferritin and vitamin D: Nutritional markers that may identify coexisting issues affecting energy, hair, immune function, or general health.

A cautious interpretation table

There is no universally accepted “functional optimal range” for every marker. Laboratories use different assays, and a clinician shouldn't apply invented targets to override a validated diagnosis.

Lab Marker	Conventional Range	Functional Optimal Range	Clinical Significance in Menopause
TSH	Laboratory-specific	Individualized within the treatment target	Helps guide replacement, but symptoms and free hormones add context
Free T4	Laboratory-specific	Assay and context dependent	Helps assess circulating available T4
Free T3	Laboratory-specific	Assay and context dependent	Adds information about active hormone status
Reverse T3	Laboratory-specific	No universally accepted optimal target	Requires cautious interpretation
TPO antibodies	Laboratory-specific	Negative is generally less suggestive of autoimmunity	Supports autoimmune evaluation when elevated
Tg antibodies	Laboratory-specific	Negative is generally less suggestive of autoimmunity	Adds autoimmune thyroid context
SHBG	Laboratory-specific	Context dependent	May reflect combined thyroid and sex-hormone influences
Ferritin	Laboratory-specific	Individualized to symptoms and cause	Helps assess iron status
Vitamin D	Laboratory-specific	Individualized to health context	Identifies possible nutrient insufficiency

Oral estrogen can change thyroid-binding protein physiology and may increase thyroid hormone requirements. Because menopause can alter the baseline over time, a single panel shouldn't be interpreted without knowing when treatment started, whether a dose changed, and how symptoms evolved.

A patient preparing for evaluation may also find the thyroid support guide useful, along with the article on thyroid problems with a normal TSH. For thyroid-specific preparation, complete thyroid panel guidance can help organize questions for a licensed clinician.

Nutrition and Supplement Strategies for Dual Support

Nutrition can't diagnose or replace treatment for hypothyroidism, but it can support the systems that influence energy, sleep, metabolic health, and recovery. A practical plan begins with adequate protein and fiber, minimally processed foods, stable meal timing, and correction of confirmed nutrient insufficiencies.

Selenium, zinc, and iron participate in thyroid hormone production and metabolism. Supplementation should follow dietary assessment and laboratory findings, because unnecessary high-dose supplementation can create harm, especially with iodine and iron.

Food first, then targeted support

A varied anti-inflammatory eating pattern can include vegetables, legumes, berries, nuts, seeds, whole grains, and appropriately tolerated protein sources. Flaxseed and fermented soy provide phytoestrogen compounds, but they shouldn't be presented as a substitute for thyroid therapy or menopause treatment. People taking levothyroxine should separate the medication from substances that interfere with absorption according to prescribing instructions.

Gut function also matters for overall health. Constipation, low fiber intake, food intolerance, and disrupted sleep can worsen the symptom burden that patients attribute to hormones. Probiotics and L-glutamine may be considered in selected cases, but the evidence and indication depend on the individual, and claims about a fixed percentage of thyroid conversion in the gut aren't established by the verified data available here.

Supplements require medication awareness

• Magnesium glycinate: Often selected in the evening for magnesium support (for example, Magnesium Glycinate Powder) and may be useful when sleep quality or muscle tension is a concern. It should be separated from levothyroxine when advised by the prescriber because minerals can interfere with absorption.
• Selenium: May support thyroid antioxidant defenses and hormone metabolism when dietary intake is inadequate. Dose selection should account for total intake from food and supplements. The guide to the best vitamins for thyroid health covers selenium, zinc and iron in more detail.
• B vitamins: A vitamin B supplement can support normal metabolic and nervous-system nutrient intake without acting as thyroid replacement. Cataplex® B, 360 Tablets is a whole-food B-vitamin supplement that Standard Process describes as supporting carbohydrate metabolism and cellular energy reactions; the suggested use is two tablets per meal, or as directed. Check the label for allergens.

Ashwagandha and maca are sometimes marketed for stress or menopausal support, but they aren't automatically appropriate for people with thyroid disease. Ashwagandha may affect thyroid physiology and can interact with thyroid medication, while product quality and individual risk factors vary. A licensed clinician should review these options before use.

For additional education, see natural hormone balance supplements. Supplements should complement, not obscure, diagnostic evaluation.

Medication Adjustments and Red Flags During Menopause

Menopausal hormone therapy and thyroid replacement can be used together, but the combination requires monitoring. Oral estrogen can increase thyroid-binding globulin, which may reduce the free fraction of circulating thyroid hormone and increase levothyroxine requirements in some patients. Transdermal estrogen has a different absorption pathway and may have less effect on hepatic protein production, but individual monitoring still matters.

The European Menopause and Andropause Society's 2024 position statement highlights the diagnostic and treatment dilemmas when thyroid disease and menopause overlap and calls for cautious, personalized treatment decisions in this age group (EMAS, Maturitas, 2024). A 2023 review adds that a suppressed TSH is linked with higher cardiovascular and all-cause mortality, and that TSH suppression should be avoided in peri- and postmenopausal women treated for hypothyroidism (Frank-Raue and Raue, 2023).

When to reassess treatment

New palpitations, unexplained weight change, worsening fatigue, sleep disruption, or persistent symptoms after starting oral menopausal hormone therapy should prompt medication review. Thyroid tests should be checked 4–6 weeks after a dose adjustment and then annually, according to a clinical review; after starting oral menopausal hormone therapy, TSH may need rechecking after 2–3 months, which the authors note is not necessary with transdermal estrogen (Frank-Raue and Raue, 2023).

Treatment decisions for subclinical hypothyroidism require restraint. A 2023 review concludes that L-thyroxine may be indicated when TSH is above 10 mIU/L in younger and middle-aged adults with consistent symptoms, and that European guidance is very cautious about treating milder elevations (Frank-Raue and Raue, 2023).

Red flags

Urgent medical evaluation is appropriate for chest pain, fainting, a sustained rapid or irregular heartbeat, severe functional decline, marked confusion, significant neck swelling, or signs of severe hypothyroidism such as hypothermia and non-pitting edema. Severe depression, rapidly worsening cognition, or sudden extensive hair loss also require prompt clinical assessment.

The treatment guideline warns against thyroid hormone excess and subnormal TSH values below 0.1 mIU/L, particularly in older adults and postmenopausal women (Jonklaas et al., 2014). A functional medicine framework can help investigate contributing factors, but medication changes should remain coordinated with the prescribing clinician or endocrinologist. Resources on hormone replacement alternatives can support discussion, not self-directed treatment.

Medication note: don't stop or change prescribed thyroid medication or hormone therapy without talking to your clinician.

Common Misconceptions and Your Next Steps Forward

Subclinical hypothyroidism during menopause isn't automatically “just aging,” but it also isn't automatically a reason to prescribe thyroid hormone. A small 2025 cross-sectional study of 142 postmenopausal women in India found subclinical hypothyroidism in 22.5%, with higher BMI, dyslipidemia, and hypertension associated with thyroid dysfunction, and greater occurrence within 5–10 years after menopause (Jain et al., 2025). Those findings support careful evaluation rather than a universal treatment rule.

Another misconception is that menopausal hormone therapy eliminates the need for thyroid monitoring. Estrogen exposure can change thyroid-binding physiology, so a previously stable levothyroxine dose may require reassessment. Conversely, symptoms after starting hormone therapy may reflect sleep, mood, medication absorption, menopause, thyroid status, or several factors at once.

A broad TSH reference interval also doesn't guarantee that every clinical question has been answered. The safer framework is to distinguish symptoms, review medications and supplements, test appropriately, assess autoimmune and nutritional contributors, and follow trends over time.

A practical next step is to bring a symptom timeline, medication list, supplement list, family history, and prior thyroid results to a qualified clinician. Ask whether the evaluation should include thyroid antibodies, free thyroid hormones, medication absorption review, and appropriate menopause assessment. Treatment should target confirmed problems while protecting bone, heart, and mental health.

DrMattGianforte.com offers educational resources and clinician-curated supplements for thyroid, metabolism, gut function, stress response, and hormone balance. Browse women's health supplements to review support options, and continue the conversation with a qualified healthcare professional.

Frequently Asked Questions

Can hypothyroidism and menopause happen at the same time?

Yes. Hypothyroidism becomes more common with age, and studies show thyroid dysfunction is more prevalent in late perimenopause and postmenopause than before menopause. Because the symptoms overlap, both conditions may need evaluation.

What symptoms suggest hypothyroidism instead of menopause?

Cold intolerance, constipation, dry skin, slower heart rate, and a gradual metabolic slowdown may point more toward hypothyroidism. Hot flashes, vaginal dryness, night sweats, and cycle changes more often suggest menopause, although no symptom pattern can diagnose either condition alone.

Is TSH enough to evaluate thyroid function during menopause?

TSH is an important marker, but it may not answer every question when symptoms persist, medication changes occur, or autoimmune thyroid disease is suspected. A clinician may consider free T4, free T3, thyroid antibodies, medication review, and other tests based on the clinical context.

Can menopausal hormone therapy change thyroid medication needs?

Oral estrogen can alter thyroid-binding globulin and may increase levothyroxine requirements in some patients. TSH should be reassessed after therapy changes according to the prescribing clinician's monitoring plan.

When is levothyroxine considered for subclinical hypothyroidism?

Treatment depends on repeated laboratory results, symptoms, age, cardiovascular and bone considerations, pregnancy-related factors, and thyroid antibodies. Clinical reviews generally reserve levothyroxine for TSH values above 10 mIU/L, especially in younger and middle-aged adults with symptoms, rather than treating every mild abnormality.

Can supplements fix hypothyroidism naturally?

Supplements can't replace thyroid hormone when the thyroid cannot produce enough hormone. Nutrients such as selenium, iron, zinc, magnesium, and vitamin D may be relevant when intake or laboratory status indicates a need, but dosing and medication interactions require professional review.

How should thyroid medication be monitored after a dose change?

The clinical review cited above recommends checking TSH 4–6 weeks after a thyroid dose adjustment and annually thereafter, with additional monitoring after starting oral menopausal hormone therapy. A prescriber may use a different schedule when symptoms, pregnancy potential, illness, or medication interactions change the situation.

References

• Gietka-Czernel M. The thyroid gland in postmenopausal women: physiology and diseases. Przegląd Menopauzalny (Menopause Review). 2017. Available at PubMed Central.
• Schindler AE. Thyroid function and postmenopause. Gynecological Endocrinology. 2003. Available at PubMed.
• Hernández Valencia M, Córdova Pérez N, Zárate A. Hypothyroidism associated with worsening menopause symptoms and change with thyroid substitution therapy (article in Spanish). Ginecología y Obstetricia de México. 2008. Available at PubMed.
• Mintziori G, et al. EMAS position statement: thyroid disease and menopause. Maturitas. 2024. Available at PubMed.
• Jain C, Mishra N, Singh S, Nirat A. Prevalence and risk factors of subclinical hypothyroidism in postmenopausal women: a cross-sectional study. Bioinformation. 2025. Available at PubMed.
• Frank-Raue K, Raue F. Thyroid dysfunction in peri- and postmenopausal women: cumulative risks. Deutsches Ärzteblatt International. 2023. Available at PubMed Central.
• Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014. Available at PubMed Central.
• Kim Y, Chang Y, Cho IY, et al. The prevalence of thyroid dysfunction in Korean women undergoing routine health screening: a cross-sectional study. Thyroid. 2022. Available at PubMed.

These statements have not been evaluated by the Food and Drug Administration. Products and information on this site are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement.